I-FDA ivume isixhobo sokuqala sokudosa i-insulin ezenzekelayo Uhlobo lwe-2 sikashukela imeko.
Oku kulandela ukwanda kwesalathiso seTekhnoloji ye-Insulet SmartAdjust (i-interoperable automated glycemic controller) eboniswa kulawulo lwe-Insulet SmartAdjust. uhlobo lwe-1 sikashukela. Ngoku, obu buchwephesha bedosi ye-insulin ye-Automated buya kuboniswa kwaye bufumaneke kulawulo lwe Uhlobo lwe-2 sikashukela njengokuba.
Olu kwamkelwa yi-FDA lusekwe kwiziphumo zolingo lwezonyango kusetyenziso lwetekhnoloji ye-Insulet SmartAdjust ngabantu Uhlobo lwe-2 sikashukela kunyango lwe-insulin. Uphononongo lufumene ukuba iteknoloji ikhuselekile kwaye iphuculwe ukulawula iswekile yegazi kubathathi-nxaxheba.
I-teknoloji ye-Insulet SmartAdjust, i-interoperable automated glycemic controller yi-software elungisa ngokuzenzekelayo ukuhanjiswa kwe-insulin kumntu onesifo sikashukela ngokudibanisa ne-alternate controller-enabled insulin pump (ipompo ye-ACE) kunye ne-integrated continuous glucose monitor (iCGM).
Uhlobo lwe-2 sikashukela imeko kubantu abaninzi ayiphenduli kakuhle kulawulo olungelulo unyango kunye nonyango ngamacwecwe alwa neswekile. Abantu abanjalo kufuneka bazinikeze i-insulini kube kanye okanye nangaphezulu ngemini besebenzisa inaliti okanye ipeni ye-insulin okanye impompo ukuze bagcine izinga leswekile egazini labo likwinqanaba elikhuselekileyo. Oku kufuna ukuba bajongwe rhoqo amanqanaba eswekile yegazi ukuze bafumane iziphumo ezingcono. Isixhobo sokuDosa i-insulin esizisebenzelayo siya kuba lukhetho olunengqiqo lwabantu abanjalo abanokuphucula umgangatho wobomi babo.
***
Imithombo:
- Ukukhutshwa kweendaba ze-FDA-i-FDA Icima isiXhobo sokuQala sokuVumela iDosing ye-insulin ezenzekelayo kubantu abanesifo seswekile se-2. Ithunyelwe nge-26 Agasti 2024. Iyafumaneka e https://www.fda.gov/news-events/press-announcements/fda-clears-first-device-enable-automated-insulin-dosing-individuals-type-2-diabetes
***
